Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association

Molecular Genetics and Metabolism

Volumn 85, Issue 3, 2005, Pages 220-227

  O'Leary, Valerie B ^a   Mills, James L ^b   Pangilinan, Faith ^c   Kirke, Peadar N ^d   Cox, Christopher ^b   Conley, Mary ^b   Weiler, Andrea ^c   Peng, Kun ^e   Shane, Barry ^e   Scott, John M ^a   Parle McDermott, Anne ^a   Molloy, Anne M ^a   Brody, Lawrence C ^c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d HEALTH RESEARCH BOARD   (Ireland)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Folate; Homocysteine; MTHFR; MTR; MTRR; Neural tube defects; Polymorphism; Spina bifida

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE REDUCTASE;

AFRICAN AMERICAN; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FATHER; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC RISK; HUMAN; LINEAR SYSTEM; MOTHER; NEURAL TUBE DEFECT; NUCLEOTIDE SEQUENCE; PARAMETERS OF MEASUREMENT AND ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FERREDOXIN-NADP REDUCTASE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RISK FACTORS;

EID: 20544456790     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.02.003     Document Type: Article

References (26)

1. P.N. Kirke, A.M. Molloy, L.E. Daly, H. Burke, D.G. Weir, and J.M. Scott Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects Q. J. Med. 86 1993 703 708
2. R.P.M. Steegers-Theunissen, G.H.J. Boers, and F.J.M. Trijbels Maternal hyperhomocysteinemia: a risk factor for neural-tube defects Metabolism 43 1994 1475 1480
3. J.L. Mills, J.M. McPartlin, P.N. Kirke, Y.J. Lee, M.R. Conley, D.G. Weir, and J.M. Scott Homocysteine metabolism in pregnancies complicated by neural-tube defects Lancet 345 8943 1995 149 151
4. CDC, Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects, MMWR 41 (1992) No. RR-14.
5. M.L. Ludwig, and R.G. Matthews Structure-based perspectives on B12-dependent enzymes Annu. Rev. Biochem. 66 1997 269 313
6. 12) increases risk of spina bifida Mol. Genet. Metab. 67 1999 317 323
7. H. Olteanu, T. Munson, and R. Banerjee Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human Methionine Synthase Reductase Biochemistry 41 2002 13378 13385
8. R.M. Gueant-Rodriguez, C. Rendeli, B. Namour, L. Venuti, A. Romano, G. Anello, P. Bosco, R. Debard, P. Gerard, M. Viola, E. Salvaggio, and J.L. Gueant Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans Neurosci. Lett. 344 3 2003 189 192
9. H. Zhu, N.J. Wicker, G.M. Shaw, E.J. Lammer, S. Hendricks, L. Suarez, M. Canfield, and R.H. Finnell Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects Mol. Genet. Metab. 78 2003 216 221
10. C.A. Brown, K.Q. McKinney, J.S. Kaufman, R.A. Gravel, and R. Rozen A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease J. Cardiovasc. Risk 3 2000 197 200
11. L.C. Brody, P.J. Baker, P.S. Chines, A. Musick, A.M. Molloy, P.N. Kirke, S. Ghosh, J.M. Scott, and J.L. Mills Methionine synthase: high-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects Mol. Genet. Metab. 67 1999 324 333
12. A. Agresti Categorical data analysis 1990 Wiley New York
13. R.S. Spielman, R.E. McGinnis, and W.J. Ewens Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am. J. Hum. Genet. 52 1993 506 511
14. C.R. Weinberg, A.J. Wilcox, and R.T. Lie A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parent imprinting Am. J. Hum. Genet. 62 1998 969 978
15. W.W. Piegorsch, C.R. Weinberg, and J.A. Taylor Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies Stat. Med. 13 1994 153 162
16. A. Wilson, D. Leclerc, F. Saberi, E. Campeau, H.Y. Hwang, B. Shane, J.A. Phillips 3rd, D.S. Rosenblatt, and R.A. Gravel Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency Am. J. Hum. Genet. 63 1998 409 414
17. D.A. Swanson, M.L. Liu, P.J. Baker, L. Garrett, M. Stitzel, J. Wu, M. Harris, R. Banerjee, B. Shane, and L.C. Brody Targeted disruption of the methionine synthase gene in mice Mol. Cell. Biol. 21 4 2001 1058 1065
18. J.J. Pietrzyk, M. Bik-Multanowski, M. Sanak, and M. Twardowska Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida J. Appl. Genet. 44 2003 111 113
19. C.A. Hobbs, S.L. Sherman, Y. Ping, S.E. Hopkins, C.P. Torfs, R.J. Hine, M. Pogribna, R. Rozen, and S.J. James Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down Syndrome Am. J. Hum. Genet. 67 2000 623 630
20. V.B. O'Leary, A. Parle-McDermott, A.M. Molloy, P.N. Kirke, Z. Johnson, M. Conley, J.M. Scott, and J.L. Mills MTRR and MTHFR polymorphism: link to Down syndrome? Am. J. Med. Genet. 107 2002 151 155
21. P. Bosco, R.M. Gueant-Rodriguez, G. Anello, C. Barone, F. Namour, F. Caraci, A. Romano, C. Romano, and J.L. Gueant Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome Am. J. Med. Genet. 121A 3 2003 219 224
22. K. Matsuo, N. Hamajima, T. Hirai, T. Kato, M. Inoue, T. Takezaki, and K. Tajima Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer Asian Pac. J. Cancer Prev. 3 4 2002 353 359
23. N. Akar, E. Akar, D. Ozel, G. Deda, and T. Sipahi Common mutations at the homocysteine metabolism pathway and pediatric stroke Thromb. Res. 102 2 2001 115 120
24. P.F. Jacques, A.G. Bostom, J. Selhub, S. Rich, R.C. Ellison, J.H. Eckfeldt, R.A. Gravel, and R. Rozen National Heart, Lung and Blood Institute, National Institutes of Health. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study Atherosclerosis 166 1 2003 49 55
25. E.S. Brilakis, P.B. Berger, K.V. Ballman, and R. Rozen Methylenetetrahydrofolate reductase (MTHFR) 677C > T and methionine synthase reductase (MTRR) 66A > G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid Atherosclerosis 168 2 2003 315 322
26. M.T. Doolin, S. Barbaux, M. McDonnell, K. Hoess, A.S. Whitehead, and L.E. Mitchell Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida Am. J. Hum. Genet. 71 5 2002 1222 1226